Physician profile
Travis L Buzzard
NPI 1730290545
$524.38
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $25.86 · 2022: $169 · 2023: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $160.59 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $82.69 | 2022-2023 | Breztri |
| Glaxosmithkline, LLC. | $64.62 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $38.49 | 2022-2023 | Austedo Xr |
| Pfizer INC. | $37.66 | 2022 | |
| Lilly USA, LLC | $33.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.16 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $19.62 | 2019 | |
| Corium, LLC | $15.80 | 2023 | Azstarys |
| Grifols USA, LLC | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Buzzard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.